Obesity News and Research

Latest Obesity News and Research

Orexigen Therapeutics announces submission of Contrave NDA for treatment of obesity

Orexigen® Therapeutics, Inc. announced that the Company has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Contrave® (naltrexone SR/bupropion SR), its investigational drug for the treatment of obesity. The NDA is based on a substantial body of evidence gathered through the Contrave Obesity Research (COR) clinical program, which included over 4,500 patients.

1 Apr 2010

Personalized online resource to help Canadians achieve healthy weight loss

A Heart and Stroke Foundation survey of almost 2,000 Canadians found that 62% reported intentionally losing five or more pounds over the past five years but failed to keep the weight off. And 70% of those who were overweight or obese regained all or even more pounds after their weight-loss efforts.

1 Apr 2010

Positive results from Ardea Biosciences' Phase 2b study of RDEA594 for hyperuricemia and gout

Ardea Biosciences, Inc. announced positive, preliminary, top-line results from its Phase 2b monotherapy study of RDEA594, its lead product candidate for the treatment of hyperuricemia and gout. In this 28-day, randomized, double-blind, placebo-controlled, dose-escalation study, 123 gout patients with hyperuricemia (serum urate levels greater than or equal to 8 mg/dL) received 200 mg once-daily (qd) RDEA594, 400 mg qd RDEA594, 600 mg qd RDEA594 or matching placebo.

1 Apr 2010

High-fructose corn syrup makes rats fat: Princeton University study questioned

"HFCS makes rats fat? I can hardly believe that Princeton sent out a press release yesterday announcing the results of this rat study. The press release says: "Rats with access to high-fructose corn syrup gained significantly more weight than those with access to table sugar, even when their overall caloric intake was the same."

31 Mar 2010

Astellas Pharma forms agreement to review certain confidential information of OSI Pharmaceuticals

OSI Pharmaceuticals, Inc. today announced that it had entered into an agreement with Astellas Pharma Inc., under which Astellas will be able to review certain confidential information related to OSI.

31 Mar 2010

Fat-rich breakfast may help prevent metabolic syndrome, says study

The age-old maxim "Eat breakfast like a king, lunch like a prince and dinner like a pauper" may in fact be the best advice to follow to prevent metabolic syndrome, according to a new University of Alabama at Birmingham (UAB) study.

31 Mar 2010

Drinking orange juice with fast-food meal may help prevent vascular inflammation

Eating foods containing flavonoids -- orange juice, in this case -- along with a high-fat, high-carbohydrate fast-food meal neutralizes the oxidative and inflammatory stress generated by the unhealthy food and helps prevent blood vessel damage, a new study by University at Buffalo endocrinologists shows.

31 Mar 2010

Hsp90 inhibitors may help fight cardiovascular disease, say researchers

New drugs that are helping fight a multi-front war on cancer may do the same for cardiovascular disease, Medical College of Georgia researchers said.

31 Mar 2010

Overweight infants may experience delayed motor skills

Those cute little rolls of fat some infants have may actually slow their ability to crawl and walk, according to a new study by the University of North Carolina at Chapel Hill.

31 Mar 2010

Asclera injection receives FDA approval

The U.S. Food and Drug Administration today approved Asclera (polidocanol) injection for the treatment of small types of abnormally swollen or twisted veins called varicose veins.

31 Mar 2010

Posting calorie counts on menus and menu boards also needed in Ontario

US President Barack Obama's groundbreaking health care legislation includes a provision requiring restaurants to post calories on menus and menu boards. For the past year, Ontario's doctors have been calling for similar action from the government, chain restaurants and school cafeterias in the province and believe now is the perfect time for this initiative to be implemented.

30 Mar 2010

Preventive health care researchers meet to outline vision for evidence-based prevention in health care

Leading preventive health care researchers, physicians and executives assembled at U.S. Preventive Medicine® Friday to outline their vision for advancing evidence-based prevention in health care.

30 Mar 2010

Gout incidence lower in women than men: Study

Researchers from Boston University School of Medicine found that women with serum uric acid levels over 5 mg/dl had a significantly lower risk of developing gout than men. This study, the first to examine the relationship between uric acid levels and gout risk in women, also evaluated purported risk factors for gout and found that increasing age, obesity, hypertension, alcohol use, and diuretic use to be among leading contributors for women.

30 Mar 2010

Analysis indicates substantial underdiagnosis of obesity when BMI used compared to DEXA scan

A retrospective analysis of 1,234 Americans indicated a substantial underdiagnosis of obesity when Body Mass Index was used compared to the Dual Energy X-ray Absorptiometry scan. This analysis will be released on Friday, April 23, 2010 at the American Association of Clinical Endocrinologists 19th Annual Meeting & Clinical Congress in Boston.

30 Mar 2010

Nationwide campaign to repeal government controlled national health care program

Americans for Responsible Health Care announced today that it is launching a nationwide campaign to collect ten million signatures of Americans determined to repeal, reform and replace the new government controlled national health care program that was enacted despite the public's overwhelming opposition.

30 Mar 2010

CEO Roundtable on Cancer announces Gold Standard accreditation for Susan G. Komen for the Cure

Susan G. Komen for the Cure®, the world's largest breast cancer organization, has received CEO Cancer Gold Standard™ accreditation, recognizing the organization's commitment to reducing the risk of cancer for its employees and their families by promoting healthy lifestyle choices, by encouraging early detection through cancer screenings, and by ensuring access to quality treatment.

30 Mar 2010

Devereux Florida's Viera Campus secures $100,000 in federal funds

Devereux Florida's Viera Campus has secured $100,000 in federal funds to renovate a 21,000 square foot facility that serves over 500 children each year who are in need of improved physical, social and emotional health.

30 Mar 2010

GEMI announces addition of newest member, MedImmune

"We are pleased to welcome MedImmune to GEMI," said GEMI Chair, Moe Bechard, Diversey, Inc., "MedImmune is an innovative, growing company whose mission, values and goals make them a leader in their business sector. Working collaboratively with other GEMI members, they will provide our organization with valuable insight, and be an excellent addition to GEMI."

30 Mar 2010

GenVec announces discontinuation of TNFerade PACT trial for pancreatic cancer

GenVec, Inc. announced today that it is discontinuing its Phase 3 clinical trial of TNFerade™ in patients with locally advanced pancreatic cancer based on results of an interim analysis. This interim analysis of overall survival, conducted after the 184th death (two-thirds of total expected events), was designed to determine whether the study should continue.

30 Mar 2010

Cephalon receives FDA Complete Response Letter for NUVIGIL supplemental new drug application

Cephalon, Inc. today announced the company has received a Complete Response letter from the U.S. Food and Drug Administration (FDA) for its supplemental new drug application for NUVIGIL® (armodafinil) Tablets [C-IV] in the treatment of patients with excessive sleepiness associated with jet lag disorder resulting from eastbound travel.

30 Mar 2010

Obesity News and Research

Latest Obesity News and Research

Orexigen Therapeutics announces submission of Contrave NDA for treatment of obesity

Personalized online resource to help Canadians achieve healthy weight loss

Positive results from Ardea Biosciences' Phase 2b study of RDEA594 for hyperuricemia and gout

High-fructose corn syrup makes rats fat: Princeton University study questioned

Astellas Pharma forms agreement to review certain confidential information of OSI Pharmaceuticals

Fat-rich breakfast may help prevent metabolic syndrome, says study

Drinking orange juice with fast-food meal may help prevent vascular inflammation

Hsp90 inhibitors may help fight cardiovascular disease, say researchers

Overweight infants may experience delayed motor skills

Asclera injection receives FDA approval

Posting calorie counts on menus and menu boards also needed in Ontario

Preventive health care researchers meet to outline vision for evidence-based prevention in health care

Gout incidence lower in women than men: Study

Analysis indicates substantial underdiagnosis of obesity when BMI used compared to DEXA scan

Nationwide campaign to repeal government controlled national health care program

CEO Roundtable on Cancer announces Gold Standard accreditation for Susan G. Komen for the Cure

Devereux Florida's Viera Campus secures $100,000 in federal funds

GEMI announces addition of newest member, MedImmune

GenVec announces discontinuation of TNFerade PACT trial for pancreatic cancer

Cephalon receives FDA Complete Response Letter for NUVIGIL supplemental new drug application

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Obesity News and Research

Latest Obesity News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in